Introduction
The systematic application of coping strategies in treatment settings can be an important therapeutic tool (1) , providing patients with psychotic illness a means to gain control over their symptoms (2) (3) (4) (5) (6) (7) . Breier and Strauss (8) studied coping mechanisms in a self-control framework, and found that almost all patients reported attempts to gain control over their symptoms using different coping strategies. It has been suggested that self-initiated coping strategies enhance control over psychotic symptoms (4, 9) , but it remains uncertain to what extent self-initiated coping strategies are effective in alleviating symptoms. Some studies suggest that the quality of coping is determined more by the number of coping mechanisms than the type of coping (10) (11) (12) . Falloon and Talbot (13) , however, reported that patients who were the least handicapped by their symptoms used fewer coping strategies, but that consistency of used coping strategies was more important. Other work suggests that especially cognitive coping strategies contribute preferentially to attributions of control over symptoms (14) . More recent work stressed the importance of active versus passive coping strategies in dealing with psychotic symptoms (15) .
We wished to investigate to what extent selfinitiated coping strategies were associated with subjective experience of control over psychotic symptoms. In addition, the degree to which associations differed as a function of coping type or number of coping mechanisms was investigated per symptom.
Material and methods
The patient sample and instruments have been described in a companion paper (16) . Of the five interviews described in the companion paper, the second interview by M.B. (who developed the instrument) was a priori chosen and used for the current analyses. Data were available for 21 patients.
Analyses
Analyses were conducted with the STATA statistical program (17) . A data file was constructed in which each of the 21 patients included in the study contributed 14r13=182 observations: one for each of the different combinations of 14 original coping mechanisms and 13 original symptoms of the MACS (16) . This was the most detailed level of analysis possible, as the MACS assesses for each different symptom whether or not an individual uses any of the 14 coping strategies. Thus, for each of these 182 combinations, patients could have a score of either 0 (indicating they did not use the coping strategy for the symptom) or 1 (indicating they did use the coping strategy for the symptom). After construction of the file, the symptoms were regrouped into six classes and coping strategies into five classes based on the factor analysis described in the companion paper (16) , retaining the format of 182 (=14 coping strategiesr13 symptoms) binary coping scores per individual. In this file, containing 21 subjectsr182=3822 observations, the binary coping variable was the dependent variable, and control the independent variable. Interactions were fitted with coping type and type of symptom and assessed by likelihood ratio tests.
Effect sizes were expressed as odds ratios (OR) from the logistic regression model of the binary coping outcome. As observations were clustered within individuals, the CLUSTER and ROBUST options were used in the STATA logistic regression analyses. The CLUSTER option combined with the ROBUST option allows for the use of observations which are not independent within clusters (in this case: within individuals) and obtains the HuberWhite-Sandwich estimator of variance instead of the traditional variance estimator. These procedures result in standard errors that are adjusted for clustering within people.
Only observations were included of presence or absence of coping strategy that were associated with presence of a symptom, resulting in n=1820 of 3822 maximum observations (inclusion of all observations regardless of presence of symptom would have resulted in associations merely reflecting presence or absence of symptoms).
Results
Descriptive statistics of the sample are given in the companion paper (11) .
Coping in relation to coping type and type of symptom Both coping type and type of symptom had effects on the number of coping strategies. Symptomatic coping was by far the most prevalent strategy, whereas passive illness behaviour was the least frequent (Table 1 ). In the logistic regression analysis, the odds of using symptomatic coping were nearly 10 times higher than use of the passive illness behaviour strategy, whereas the odds of active problem-solving, passive problem-avoiding and active problem-avoiding were around 2-3 times higher. The variation in the number of coping strategies used varied less with type of symptom ( Table 2 ). The odds of using coping strategies were around two times higher with depressive symptoms and lowest for symptoms of euphoria, hostility and negative symptoms. The effects of coping type and type of symptom were independent of each other (assessed by entering both together in the logistic regression equation).
Coping and control
There was a positive and significant association between coping and control (OR control over seven levels: 1.07, 95% CI: 1.03, 1.12), which remained after adjustment for coping type and type of symptom (OR=1.09, 95% CI: 1.03, 1.15). However, there was a significant interaction between control and the 14 different coping strategies in their effects on coping (likelihood ratio test: x 2 =108.47, df=13, P<0.0001). Stratified analyses revealed that the associations between coping and control were very large and positive in the case of all non-symptomatic coping strategies, especially the active problem-solving and active problem-avoiding strategies, but negative in the case of symptomatic coping (Table 3) . Although not significant at conventional alpha, there was a very large effect size for use of non-prescribed substances (OR=5.75, 95% CI: 0.60, 55.01). The effect of control was not modified by type of symptom (likelihood ratio test: x 2 =3.01, df=5, P=0.70).
Discussion
As reported in previous studies, we found that people with a diagnosis of schizophrenia reported the use of a diversity of coping strategies to experience control over their symptoms (18) (19) (20) (21) (22) (23) . In addition, this study quantified some of the relations between coping and control in a useful way.
Patients who experienced control over symptoms especially used active, mostly cognitive, coping Subjective control over psychotic symptoms (MAC-II)?
strategies. These results are in line with earlier studies, showing that individuals with a diagnosis of schizophrenia who felt they coped better with stress and symptoms used more active cognitive coping strategies (1, 24) and to some degree care-related coping strategies and behavioural coping strategies. The finding that active cognitive coping favoured control was also shown by Pallanti and colleagues in a young group of patients with a first episode of schizophrenia. Cognitive coping strategies, especially problem-focused styles, reduced relapse rates and shortened the duration of hospitalization (12, 23) . We found that problem-solving was the most frequently reported coping mechanism among the different coping strategies after symptomatic coping strategies. Although passive illness behaviour was the least frequently used coping strategy, it did contribute significantly to experience of control over symptoms, including self-medication with nonprescribed substances and prescribed medications. Patients who used their medication regularly reported a significantly better subjective response to medication in a previous study (25) . In contrast, however, Marley and colleagues (26) reported in another study that the majority of subjects placed little emphasis on medication as a cause of feeling Table 1 . Amount of coping by coping domain given the presence of a psychotic symptom. For example, the sixth row relates to 'help-seeking'. Of 130 possible instances of coping through help-seeking for 13 possible symptoms in 21 people, individuals indicated the use of coping in 8.46%. In comparison, the proportion in the baseline category 'use of non-prescribed substances' was much lower (3.85%). The odds ratio of these two probabilities is 2.31 (column 4), indicating that patients are 2.31 times more likely to cope through help-seeking than through non-prescribed substances better. Our data in addition confirm previous suggestions that a small group of patients is having recourse to non-prescribed substances as a means of self-medication for psychotic symptoms (27) (28) (29) . The clinical implication is that it is important to assess to what degree self-medication serves to enhance subjective control over psychotic symptoms before treatment of substance misuse is included in the treatment plan. Symptomatic coping strategies negatively influenced control experience. This suggests that the outward manifestations of psychopathology serve to augment feelings of being out of control, and confirms earlier results reported by Carr (18) . The fact that this was the most frequently used coping strategy makes it clinically relevant, as a large proportion of feelings of being out of control may be attributable to this type of dysfunctional coping.
The MACS assesses coping strategies separately for different symptoms. Depressive symptoms were associated with the highest number of coping strategies followed by cognitive symptoms, positive symptoms, negative symptoms and hostility and euphoria. We are unaware of previous reports analysing the number of coping strategies in psychotic illness as a function of symptoms. Coping strategy enhancement therapy and symptom management programmes focus typically on positive symptoms, although the implicit goal of such techniques is to reduce anxiety and depression associated with symptoms rather than simply reduction of the positive symptoms themselves (1, 13, 20, 30) . People with a diagnosis of schizophrenia very often suffer with depressive symptoms (26) and depressive symptoms have the strongest effects on subjective need for care, quality of life and service satisfaction (31) . The fact that depressive symptoms generated more coping on the part of the patient is in agreement with these earlier findings, and implies that coping enhancement for depressive symptoms can have an important impact on many patient outcomes.
The above results should be viewed in the light of several potential limitations. The study group was small, 21 subjects. The limited number of subjects should lead to caution in interpreting the result of the factor analysis of coping strategies, as these analyses typically need at least 10 subjects for each included variable. The symptom and coping groupings used in the current study nevertheless had face validity.
The cross-sectional study design also introduces limitations. Thus, although it is logical to assume that coping results in more control over symptoms, it cannot be excluded that experience of control enhances the use of coping strategies or the reporting of more coping strategies. However, such a mechanism cannot explain the negative association between symptomatic coping and control.
Coping and experience of symptom control are dynamic entities with within-and between day fluctuations that cannot be captured by a crosssectional instrument. However, the data (described in the companion article (16)) showed good correlation of coping and control experience between the first and second interviews. The dynamic and reciprocal interactions between distress, coping and control also could not be studied within this design. A more detailed, longitudinal study is necessary to study simultaneously the different paths between these variables.
The study group was homogeneous, but cannot be considered representative of all patients with a diagnosis of schizophrenia. The subjects were all living outside hospital and not in need of hospital care. They all were able to communicate well and had had their illness for some time.
While accepting the above-mentioned limitations, we feel that the results suggest nevertheless that the systematic study of coping in clinical settings may be useful in giving direction to coping enhancement therapies in individuals who experience distress caused by psychotic symptoms.
